Standard Biotools (LAB) Short-term Investments (2011 - 2026)
Standard Biotools (LAB) posted quarterly Short-term Investments of $189.4 million for Q1 2026, up 76.71% year-over-year from $107.2 million in Q1 2025, and up 183.91% quarter-over-quarter from $66.7 million in Q4 2025.
Standard Biotools (LAB) Short-term Investments (2011 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Short-term Investments for 15 consecutive years, with $189.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Short-term Investments rose 76.71% year-over-year to $189.4 million; the TTM figure through Mar 2026 stood at $189.4 million (up 76.71% YoY), while the FY2025 annual figure was $66.7 million, down 47.12% from the prior year.
- Short-term Investments advanced to $189.4 million in Q1 2026 per LAB's latest filing, from $66.7 million in the prior quarter.
- Across five years, Short-term Investments topped out at $189.4 million in Q1 2026 and bottomed at $40.9 million in Q1 2023.
- Historically, Short-term Investments has averaged $105.9 million across 5 years, with a median of $107.2 million in 2025.
- Annual changes were most pronounced in 2023 — Short-term Investments tumbled 60.63% — and 2024, when it soared 328.7%.
- Standard Biotools' Short-term Investments stood at $84.5 million in 2022, then slipped by 25.2% to $63.2 million in 2023, then jumped by 99.63% to $126.1 million in 2024, then sank by 47.12% to $66.7 million in 2025, then surged by 183.91% to $189.4 million in 2026.
- Business Quant data shows LAB's Short-term Investments at $189.4 million in Q1 2026, $66.7 million in Q4 2025, and $65.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 206.69 Mn |
| Mar 31, 2026 | 189.40 Mn |
| Dec 31, 2025 | 66.71 Mn |
| Sep 30, 2025 | 65.49 Mn |
| Jun 30, 2025 | 78.47 Mn |
| Mar 31, 2025 | 107.18 Mn |
| Dec 31, 2024 | 126.15 Mn |
| Sep 30, 2024 | 155.68 Mn |
| Jun 30, 2024 | 124.90 Mn |
| Mar 31, 2024 | 175.23 Mn |
| Dec 31, 2023 | 63.19 Mn |
| Sep 30, 2023 | 49.20 Mn |
| Mar 31, 2023 | 40.87 Mn |
| Dec 31, 2022 | 84.48 Mn |
| Sep 30, 2022 | 124.97 Mn |
| Jun 30, 2022 | 136.85 Mn |
| Jun 30, 2020 | 2.43 Mn |
| Mar 31, 2020 | 13.49 Mn |
| Dec 31, 2019 | 36.98 Mn |
| Sep 30, 2019 | 36.88 Mn |